Therapy News and Research

RSS

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

29 Oct 2018

Study finds kill code mechanism embedded in every cell to extinguish cancer

A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study. As soon as the cell's inner bodyguards sense it is mutating into cancer, they punch in the kill code to extinguish the mutating cell.

29 Oct 2018

Researchers develop new app that reminds users to relax and prevent stress

Whether at work or at leisure - more and more people are feeling stressed. This makes it all the more important to learn to consciously relax in order to get stress under control.

29 Oct 2018

Study investigates how brain lesion affects child’s language localization and abilities

Children with brain injuries are able to reorganize their language relevant areas into other, healthy brain areas and thus maintain their ability to speak.

29 Oct 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Getting right level of leptin may help protect cardiovascular health

Like that famous bowl of porridge, when leptin levels are "just right" they help protect our cardiovascular health, scientists say.

29 Oct 2018

New approach may lead to protective vaccines for immunocompromised patients

A study led by Som Nanjappa at the University of Illinois College of Veterinary Medicine identifies a cellular target that may improve efficacy in vaccines designed to protect immunocompromised individuals from potentially deadly opportunistic infections.

26 Oct 2018

Cook Regentec collaborates with Indiana University School of Medicine to develop new technologies

ook Regentec, Cook Group's first company in Indianapolis, cut the ribbon Wednesday on its new facility on Indiana Avenue and announced a collaboration with Indiana University School of Medicine aimed at developing tools and technologies that advance solutions in the emerging areas of immunotherapy, precision medicine, drug delivery, regenerative medicine and bioprinting.

26 Oct 2018

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Stroke specialists often see conditions known as stroke "mimics" and "chameleons" that can complicate accurate diagnoses, Loyola Medicine neurologists report in the November 2018 issue of Neuroimaging Clinics of North America.

26 Oct 2018

Molecular breakthrough may improve prognosis for pancreatic cancer

Scientists have discovered a method by which fibroblasts in the stroma of pancreatic tumors can be reprogrammed to suppress tumor cell growth.

26 Oct 2018

Raman microscopy can help detect cancer drug resistance

Biophysicists at Ruhr-Universität Bochum have demonstrated that Raman microscopy can be used to detect the resistance of tumor cells to cancer drugs.

26 Oct 2018

Active ingredient in magic mushrooms could soon become a depression treatment

The active ingredient in magic mushrooms is psilocybin. Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushroom and is the reason behind the “high” provided by the magic mushrooms. Now, Psilocybin may soon achieve legal status to be used for treatment of difficult to treat depressive illness.

26 Oct 2018

Woman's PR-status may help develop personalized approach to treating endometriosis

Endometriosis -- a condition caused by uterine tissue growing outside of the organ -- affects 10% of reproductive-aged women, whom it causes chronic pain that is significant and debilitating.

25 Oct 2018

Combination therapy enhances wound healing

By incorporating a gene-suppressing drug into an over-the-counter gel, researchers at Albert Einstein College of Medicine and their colleagues cut healing time by half and significantly improved healing outcomes compared to control treatments.

25 Oct 2018

Potential new biomarkers may aid early detection of glaucoma

Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients. Moreover, they ascertained that the mutation of a certain gene in mice causes intraocular pressure elevation.

25 Oct 2018

Global leaders in medical and surgical eye care to convene in Chicago to attend AAO 2018

Thousands of eye physicians and surgeons this week will convene in Chicago to attend AAO 2018, the American Academy of Ophthalmology's 122nd annual meeting.

25 Oct 2018

Researchers use MRI to watch how electrical stimulation could cure gastrointestinal disorders

More than 60 million people in the U.S. suffer from disorders in the gastrointestinal tract that could be cured by electrical stimulation, but scientists don't fully understand the therapy's effects on a critical organ: the stomach.

25 Oct 2018

Crowdfunding campaigns could be raising money for quackery

A research letter has shown that when well meaning and gullible individuals donate for crowdfunding campaigns to raise money for medical treatments, some of them may not be for the benefit of the patients. The money might be used for useless quack therapies which could sometimes be dangerous

25 Oct 2018

Therapy News and Research

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

Study finds kill code mechanism embedded in every cell to extinguish cancer

Researchers develop new app that reminds users to relax and prevent stress

Study investigates how brain lesion affects child’s language localization and abilities

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Getting right level of leptin may help protect cardiovascular health

New approach may lead to protective vaccines for immunocompromised patients

Cook Regentec collaborates with Indiana University School of Medicine to develop new technologies

High-impact clinical trial results could affect kidney-related medical care

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Molecular breakthrough may improve prognosis for pancreatic cancer

Raman microscopy can help detect cancer drug resistance

Active ingredient in magic mushrooms could soon become a depression treatment

Woman's PR-status may help develop personalized approach to treating endometriosis

Combination therapy enhances wound healing

Potential new biomarkers may aid early detection of glaucoma

Global leaders in medical and surgical eye care to convene in Chicago to attend AAO 2018

Researchers use MRI to watch how electrical stimulation could cure gastrointestinal disorders

Crowdfunding campaigns could be raising money for quackery

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News